Probiotics from the Lactobacilli and Bifidobacteria genera are some of the most commonly studied and used. Two specific probiotic strains, Lactobacillus rhamnosus GG (LGG®)* and Bifidobacterium animalis subsp. lactis BB-12 (BB-12®)*, have been extensively researched for safety and efficacy, particularly in the pediatric population. The LGG® and BB-12® Research Review examines the clinical evidence for these two probiotic strains as a primary preventive and management strategy for many of the most common infectious diseases and skin disorders affecting children.
* BB-12® is a registered trademark of Chr. Hansen H/S. * LGG® is a registered trademark of Vallo Ltd.